drugset / Trial / NCT00648856

Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg

NCT00648856

Phase 1 Completed 21 enrolled Mylan Pharmaceuticals Inc
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study was to investigate the bioequivalence of Mylan's sertraline hydrochloride 100 mg tablets to Pfizer's Zoloft® 100 mg tablets following a single, oral 100 mg (1 x 100 mg) dose administration under fed conditions.

Timeline

Start
2002-12
Primary completion
2002-12
Completion
2003-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 100 mg Oral

Indications

No indication recorded.